Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.37M Buy
36,943
+328
+0.9% +$37.9K 2.4% 17
2026
Q1
$4.38M Buy
36,615
+22,532
+160% +$2.95M 2.54% 18
2025
Q4
$1.92M Hold
14,083
1.15% 27
2025
Q3
$2.08M Sell
14,083
-221
-2% -$30.7K 1.17% 28
2025
Q2
$1.85M Sell
14,304
-78
-0.5% -$9.45K 1.1% 28
2025
Q1
$1.72M Buy
14,382
+112
+0.8% +$13.9K 1.11% 28
2024
Q4
$1.66M Buy
14,270
+150
+1% +$19K 1.08% 28
2024
Q3
$1.91M Hold
14,120
1.22% 28
2024
Q2
$1.92M Sell
14,120
-66
-0.5% -$8.98K 1.34% 26
2024
Q1
$1.83M Sell
14,186
-490
-3% -$59.2K 1.29% 25
2023
Q4
$1.68M Sell
14,676
-395
-3% -$39.4K 1.25% 24
2023
Q3
$1.37M Buy
+15,071
New +$1.55M 1.01% 26
2023
Q1
Sell
-2,001
Closed -$221K 69
2022
Q4
$221K Buy
+2,001
New +$210K 0.2% 58
2022
Q1
Sell
-2,094
Closed -$251K 85
2021
Q4
$251K Hold
2,094
0.12% 73
2021
Q3
$259K Hold
2,094
0.13% 70
2021
Q2
$251K Hold
2,094
0.12% 70
2021
Q1
$220K Sell
2,094
-1,021
-33% -$104K 0.11% 69
2020
Q4
$317K Hold
3,115
0.15% 66
2020
Q3
$262K Hold
3,115
0.14% 63
2020
Q2
$202K Buy
+3,115
New +$206K 0.12% 63

Other funds holding XYL

Prentiss Smith & Co's XYL Position: Q2 2026 in Review

Prentiss Smith & Co increased its Xylem (XYL) stake by 0.9% in Q2 2026, buying an estimated $37.9K and bringing the position to 36,943 shares worth $4.37M. The position accounts for 2.4% of the portfolio, ranked #17.

Prentiss Smith & Co first reported a position in XYL in Q2 2020 and has held it in 20 quarters since. The position peaked at $4.38M in Q1 2026. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Prentiss Smith & Co held 36,943 shares of Xylem worth $4.37M as of Q2 2026.
  • Prentiss Smith & Co bought 328 Xylem shares in Q2 2026, an estimated $37.9K.
  • Xylem made up 2.4% of Prentiss Smith & Co's portfolio in Q2 2026, its #17 holding.
  • Prentiss Smith & Co first reported a position in Xylem in Q2 2020 and has held it in 20 quarters since.
  • Prentiss Smith & Co's Xylem position peaked at $4.38M in Q1 2026.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Prentiss Smith & Co's 13F filing for Q2 2026, filed 30 Jul 2026.